AAM
HQL

Advisors Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History

Advisors Asset Management’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.61M Sell
160,418
-7,916
-5% -$132K 0.04% 523
2025
Q4 		$2.82M Buy
168,334
+9,178
+6% +$154K 0.05% 491
2025
Q3 		$2.47M Sell
159,156
-1,017
-0.6% -$13.9K 0.04% 528
2025
Q2 		$2.05M Buy
160,173
+1,487
+0.9% +$18.3K 0.04% 566
2025
Q1 		$2.01M Buy
158,686
+2,863
+2% +$38.8K 0.04% 566
2024
Q4 		$2.04M Buy
155,823
+2,920
+2% +$42.1K 0.04% 554
2024
Q3 		$2.31M Sell
152,903
-2,646
-2% -$40K 0.04% 520
2024
Q2 		$2.2M Buy
155,549
+6,365
+4% +$86.1K 0.04% 519
2024
Q1 		$2.03M Buy
149,184
+26,107
+21% +$361K 0.04% 549
2023
Q4 		$1.66M Buy
123,077
+18,987
+18% +$234K 0.03% 581
2023
Q3 		$1.3M Sell
104,090
-15,872
-13% -$209K 0.03% 641
2023
Q2 		$1.62M Buy
119,962
+12,913
+12% +$178K 0.03% 580
2023
Q1 		$1.49M Sell
107,049
-85,328
-44% -$1.22M 0.03% 605
2022
Q4 		$2.73M Sell
192,377
-19,769
-9% -$286K 0.06% 405
2022
Q3 		$2.9M Sell
212,146
-50,149
-19% -$749K 0.06% 367
2022
Q2 		$3.73M Sell
262,295
-63,344
-19% -$957K 0.07% 312
2022
Q1 		$5.39M Sell
325,639
-46,318
-12% -$797K 0.08% 254
2021
Q4 		$7.15M Sell
371,957
-72,780
-16% -$1.46M 0.1% 200
2021
Q3 		$9.25M Buy
444,737
+8,384
+2% +$179K 0.14% 141
2021
Q2 		$9.36M Buy
436,353
+17,797
+4% +$359K 0.14% 146
2021
Q1 		$8.25M Buy
418,556
+43,754
+12% +$902K 0.13% 155
2020
Q4 		$7.4M Buy
374,802
+43,768
+13% +$809K 0.12% 153
2020
Q3 		$5.82M Buy
331,034
+65,723
+25% +$1.18M 0.11% 178
2020
Q2 		$4.76M Buy
265,311
+53,236
+25% +$913K 0.09% 214
2020
Q1 		$3.18M Buy
212,075
+79,295
+60% +$1.3M 0.08% 268
2019
Q4 		$2.31M Buy
132,780
+62,317
+88% +$1.02M 0.04% 492
2019
Q3 		$1.06M Buy
70,463
+2,922
+4% +$46.8K 0.02% 737
2019
Q2 		$1.14M Buy
67,541
+44,971
+199% +$741K 0.02% 731
2019
Q1 		$387K Sell
22,570
-22,836
-50% -$394K 0.01% 1148
2018
Q4 		$686K Sell
45,406
-1,443
-3% -$25.4K 0.01% 890
2018
Q3 		$957K Sell
46,849
-522
-1% -$10.4K 0.02% 852
2018
Q2 		$890K Sell
47,371
-2,191
-4% -$41.2K 0.02% 878
2018
Q1 		$955K Sell
49,562
-871
-2% -$17.4K 0.02% 846
2017
Q4 		$990K Sell
50,433
-66
-0.1% -$1.32K 0.02% 857
2017
Q3 		$1.08M Sell
50,499
-1,531
-3% -$32.5K 0.02% 827
2017
Q2 		$1.08M Buy
+52,030
New +$1.05M 0.02% 853
2016
Q4 		– Sell
-24,109
Closed -$452K – 1851
2016
Q3 		$452K Sell
24,109
-46,690
-66% -$880K 0.01% 1127
2016
Q2 		$1.22M Sell
70,799
-3,992
-5% -$73.7K 0.02% 818
2016
Q1 		$1.34M Sell
74,791
-117,632
-61% -$2.14M 0.02% 775
2015
Q4 		$4.55M Sell
192,423
-22,185
-10% -$550K 0.07% 393
2015
Q3 		$4.83M Sell
214,608
-12,330
-5% -$345K 0.08% 356
2015
Q2 		$6.4M Buy
+226,938
New +$6.29M 0.09% 310
2014
Q4 		– Sell
-320,748
Closed -$7.09M – 1798
2014
Q3 		$7.09M Sell
320,748
-32,658
-9% -$709K 0.1% 266
2014
Q2 		$7.34M Sell
353,406
-160,910
-31% -$3.38M 0.1% 248
2014
Q1 		$11.2M Sell
514,316
-2,786
-0.5% -$62K 0.17% 170
2013
Q4 		$10.6M Sell
517,102
-295,813
-36% -$5.74M 0.17% 166
2013
Q3 		$15.7M Sell
812,915
-127,097
-14% -$2.43M 0.28% 98
2013
Q2 		$16.7M Buy
+940,012
New +$17M 0.32% 85

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Advisors Asset Management's HQL Position: Q1 2026 in Review

Advisors Asset Management reduced its abrdn Life Sciences Investors (HQL) stake by 4.7% in Q1 2026, selling an estimated $132K and leaving 160,418 shares worth $2.61M. The position accounts for 0.04% of the portfolio, ranked #523.

Advisors Asset Management first reported a position in HQL in Q2 2013 and has held it in 48 quarters since. The position peaked at $16.7M in Q2 2013. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • Advisors Asset Management held 160,418 shares of abrdn Life Sciences Investors worth $2.61M as of Q1 2026.
  • Advisors Asset Management sold 7,916 abrdn Life Sciences Investors shares in Q1 2026, an estimated $132K.
  • abrdn Life Sciences Investors made up 0.04% of Advisors Asset Management's portfolio in Q1 2026, its #523 holding.
  • Advisors Asset Management first reported a position in abrdn Life Sciences Investors in Q2 2013 and has held it in 48 quarters since.
  • Advisors Asset Management's abrdn Life Sciences Investors position peaked at $16.7M in Q2 2013.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.